MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by STADEL, J. M.
Right arrow Articles by LEFKOWITZ, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by STADEL, J. M.
Right arrow Articles by LEFKOWITZ, R. J.

Molecular Pharmacology, Vol 16, 709-718, Copyright © 1979 by the American Society for Pharmacology and Experimental Therapeutics

Multiple Reactive Sulfhydryl Groups Modulate the Function of Adenylate Cyclase Coupled Beta-Adrenergic Receptors

JEFFREY M. STADEL 1 and ROBERT J. LEFKOWITZ 1

1 From the Howard Hughes Medical Institute Laboratory, Departments of Medicine and Biochemistry, Duke University Medical Center, Durham, North Carolina 27710

The beta-adrenergic receptor adenylate cyclase complex in the frog erythrocyte contains at least two reactive sulfhydryl groups, which have been identified by their different sensitivities to N-ethylmaleimide (NEM). Adenylate cyclase catalytic activity is completely inhibited by [NEM] = 1 mM. In contrast, ability of beta-adrenergic agonists to form a high affinity guanine nucleotide sensitive state is reduced by NEM only at concentrations ge 1 mM. The inhibition of cyclase activity did not affect high affinity agonist binding nor perturb the ability of guanine nucleotides to reduce agonist affinity as determined in direct radioligand binding assays utilizing the beta-adrenergic agonist [3H]hydroxybenzylisoproterenol and (-)isoproterenol competition for antagonist [3H]dihydroalprenolol binding. Preincubation of frog erythrocyte membranes with antagonists or guanine nucleotide did not alter the effect of NEM on agonist affinity. However, once formed by preincubation of membranes with agonist, the high affinity state is resistant to the effects of NEM. The data suggest that the sulfhydryl group modulating agonist affinity 1) is located on the receptor complex but distal to the hormonal binding site and 2) may be associated with guanine nucleotide regulation of agonist affinity.

The widely different sensitivities of adenylate cyclase activity and agonist binding affinity toward NEM have been exploited to investigate the mechanism of desensitization in frog erythrocytes. Incubation of intact erythrocytes with NEM under appropriate conditions inactivates the cyclase enzyme without altering the ability of membranes prepared from these cells to bind agonist with high affinity. This NEM treatment prior to prolonged exposure to (-)isoproterenol prevents receptor desensitization in frog erythrocytes, suggesting that agonist occupancy of a nucleotide-sensitive receptor is insufficient, by itself, to initiate the receptor regulation process.

Note:
ACKNOWLEDGMENTS The authors wish to thank Dr. Lee Limbird for critically reading the manuscript and Ms. D. Addison for helping to prepare the manuscript.

Submitted on February 20, 1979
Accepted on July 6, 1979







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1979 by the American Society for Pharmacology and Experimental Therapeutics